Vandetanib with docetaxel as second-line treatment for advanced breast cancer: a double-blind, placebo-controlled, randomized Phase II study

By Boér Katalin  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 681-687

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Efficacy and Tolerability Evaluation of Pentoxifylline in Rheumatoid Arthritis: A Double-Blind, Randomised, Placebo-Controlled Study

By Usha P.R.   Naidu M.U.R.   Datla R.  

Clinical Drug Investigation, Vol. 22, Iss. 5, 2002-05 ,pp. : 329-339

Adis International

Access to resources Recommend Favorite

Low-Level Light Therapy for Androgenetic Alopecia: A 24-Week, Randomized, Double-Blind, Sham Device–Controlled Multicenter Trial

By Kim Hyojin   Choi Jee Woong   Kim Jun Young   Shin Jung Won   Lee Seok-jong   Huh Chang-Hun  

Dermatologic Surgery, Vol. 39, Iss. 8, 2013-08 ,pp. : 1177-1183

Elsevier

Access to resources Recommend Favorite

Psychiatric Adverse Events in Randomized, Double-Blind, Placebo-Controlled Clinical Trials of Varenicline: A Pooled Analysis

By Tonstad Serena  

Drug Safety, Vol. 33, Iss. 4, 2010-04 ,pp. : 289-301

Adis International

Access to resources Recommend Favorite

Safety and Efficacy of Topical Diclofenac Sodium Gel for Knee Osteoarthritis in Elderly and Younger Patients: Pooled Data from Three Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multicentre Trials

By Baraf Herbert S.B.  

Drugs & Aging, Vol. 28, Iss. 1, 2011-01 ,pp. : 27-40

Adis International

Access to resources Recommend Favorite